Welcome to LookChem.com Sign In|Join Free

CAS

  • or

749922-35-8

Post Buying Request

749922-35-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

749922-35-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 749922-35-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,9,2 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 749922-35:
(8*7)+(7*4)+(6*9)+(5*9)+(4*2)+(3*2)+(2*3)+(1*5)=208
208 % 10 = 8
So 749922-35-8 is a valid CAS Registry Number.

749922-35-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-methoxy-N-methyl-3-(4-methoxyphenyl)propionamide

1.2 Other means of identification

Product number -
Other names N-Methoxy-3-(4-methoxy-phenyl)-N-methyl-propionamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:749922-35-8 SDS

749922-35-8Relevant articles and documents

IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY

-

Page/Page column 31; 32, (2018/03/28)

This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants. The imidazoquinoline derivatives are of formula (I):

CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS

-

Page/Page column 114, (2008/06/13)

Fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a -CH(-X1-R1)-group in the fused ring at the 1-position of the imidazo ring, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

SUBSTITUTED FUSED [1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS

-

Page/Page column 62, (2008/06/13)

Fused [1,2]imidazo[4,5-c] ring compounds, e.g., fused [1,2]imidazo[4,5-c]quinolines and [1,2]imidazo[4,5-c]naphthyridines, with a substituent, e.g., a substituted alkoxy substituent, at the 6, 7, 8, or 9-position, pharmaceutical compositions containing th

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 749922-35-8